Outcome of Myeloablative Conditioning and Unrelated Donor Hematopoietic Cell Transplantation for Childhood Acute Lymphoblastic Leukemia in Third Remission-Reference-Cited by-同舟云学术

Outcome of Myeloablative Conditioning and Unrelated Donor Hematopoietic Cell Transplantation for Childhood Acute Lymphoblastic Leukemia in Third Remission

Published:2011-12 Issue:12 Volume:17 Page:1833-1840
ISSN:1083-8791
Container-title:Biology of Blood and Marrow Transplantation
language:en
Short-container-title:Biology of Blood and Marrow Transplantation

Author:

Nemecek Eneida R.,Ellis Kristin,He Wensheng,Bunin Nancy J.,Bajwa Rajinder S.,Cheerva Alexandra,Cairo Mitchell S.,Dvorak Christopher,Duval Michel,Davies Stella,Eapen Mary,Gross Thomas G.,Hussein Ayad A.,MacMillan Margaret L.,Mehta Parinda A.,Pulsipher Michael A.,Seber Adriana,Woolfrey Ann E.,Frangoul Haydar A.,Carpenter Paul A.

Funder

National Cancer Institute (NCI), the National Heart, Lung and Blood Institute (NHLBI) and the National Institute of Allergy and Infectious Diseases (NIAID)

NHLBI and NCI

Health Resources and Services Administration

Office of Naval Research

AABB, Allos Inc, Amgen Inc

Publisher

Elsevier BV

Subject

Transplantation,Hematology

Reference26 articles.

1. Long-term results of the Children’s Cancer Group studies for childhood acute lymphoblastic leukemia 1983-2002: a Children’s Oncology Group Report;Gaynon;Leukemia,2010

2. Long-term follow-up of the United Kingdom medical research council protocols for childhood acute lymphoblastic leukaemia, 1980-2001;Mitchell;Leukemia,2010

3. Long-term results of St Jude Total Therapy Studies 11, 12, 13A, 13B, and 14 for childhood acute lymphoblastic leukemia;Pui;Leukemia,2010